1. Academic Validation
  2. Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate

Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate

  • Eur J Med Chem. 2020 Jul 15;198:112392. doi: 10.1016/j.ejmech.2020.112392.
Begüm Nurpelin Sağlık 1 Derya Osmaniye 2 Ulviye Acar Çevik 2 Serkan Levent 2 Betül Kaya Çavuşoğlu 3 Oya Büyükemir 4 Deniz Nezir 4 Abdullah Burak Karaduman 5 Yusuf Özkay 2 Ali Savaş Koparal 6 Şükrü Beydemir 4 Zafer Asım Kaplancıklı 7
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. Electronic address: bnsaglik@anadolu.edu.tr.
  • 2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.
  • 3 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bülent Ecevit University, 67600 Zonguldak, Turkey.
  • 4 Department of Biochemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.
  • 5 Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.
  • 6 Open Education Faculty, Anadolu University, 26470 Eskişehir, Turkey.
  • 7 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.
Abstract

In this study, novel dithiocarbamate-sulfonamide derivatives (3a-3k) were synthesized to investigate their inhibitory activity on purified human Carbonic Anhydrase (hCA) I and II. The IC50 and Ki values of the compounds were calculated to compare their inhibition profiles on hCA I and II isoenzymes. Acetazolamide was used as the standard inhibitor in the Enzyme inhibition assay. Compounds 3a, 3e, 3g, 3h, 3j and 3k showed notable inhibitory effects against hCA I and II. Among these compounds, compound 3h was found to be the most active derivate against both the hCA I and II Enzymes with Ki values of 0.032 ± 0.001 μM and 0.013 ± 0.0005 μM, respectively. The cytotoxicity of compounds 3a, 3e, 3g, 3h, 3j and 3k toward NIH/3T3 (mouse embryonic fibroblast cell line) was observed and the compounds were found to be non-cytotoxic. Furthermore, molecular docking studies were performed to investigate the interaction types between compound 3h and the hCA I and II Enzymes. As a result of this study a novel and potent class of CA inhibitors with good activity potential were identified.

Keywords

Carbonic anhydrase; Cytotoxicity; Dithiocarbamate; Molecular docking; Sulfonamide.

Figures
Products